Whitehawk Therapeutics, Inc. cotiza a 3.02 USD y tiene una capitalización bursátil de $172M. En los últimos 12 meses ha facturado $0 con un margen de flujo de caja libre del -1371.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its na…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.20 | $-0.32 | $-0.34 |
| Estimado | $-0.24 | $-0.26 | $-0.33 | $-0.27 |
| Sorpresa | — | +23.1% | +3.0% | -25.9% |
| Métrica | WHWK | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 89.4% | 57.0% | +32.3% |
| Operating Margin | -1601.1% | -38.6% | -1562.5% |
| Net Margin | -288.3% | -33.6% | -254.7% |
| FCF Margin | -1371.4% | -13.9% | -1357.5% |
| ROE | -15.1% | -40.4% | +25.3% |
| ROA | -13.7% | -32.0% | +18.3% |
| Current Ratio | 10.26 | 2.84 | +7.42 |
| Debt / Equity | — | 0.28 | — |